drugset / Trial / NCT02799589

Remifentanil-dexmedetomidine Anesthesia With a Caudal for Elective Surgery. (Remi-dex)

NCT02799589

Phase 4 Withdrawn Mofya Diallo
NaSingle-groupOpen-labelTreatment

Summary

This study intends to show the efficacy of remifentanil-dexmedetomidine infusions in combination with a caudal block for patients ages 1 year to 3 years old receiving elective surgery to investigate alternatives to the currently used volatile anesthetics.

Timeline

Start
2016-07
Primary completion
2017-08
Completion
2017-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg
Subject Dexmedetomidine Other / unclassified 0.7 ug/kg
Subject Remifentanil Small molecule 0.05 ug/kg
Subject Remifentanil Small molecule 0.5 ug/kg
Subject Ropivacaine Other / unclassified 0.2 % Other
Subject Ropivacaine Other / unclassified 1 unknown Other

Indications

No indication recorded.